Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Kidney Int. 2012 May 23;82(7):737–747. doi: 10.1038/ki.2012.176

Figure 2. FGF23 is an independent risk factor for mortality in CKD stages 2–4.

Figure 2

The cumulative incidence of death of CKD stage 2–4 patients increases significantly with ascending quartiles of baseline FGF23 levels in unadjusted analyses (plot) and after full multivariable adjustment (hazard ratios and 95% confidence intervals in the inset).86